China Healthcare Weekly (Mar.31) - 8th National VBP Result, Chinese Patent Medicine VBP, AIM Vaccine
⬇ $AIM Vaccine(06660)$ - The 8th national VBP released results.The impact of VBP on companies is decreasing. Chinese patent medicine VBP is coming, but some companies can cope well.AIM doesn’t have long-term investment value.
Continue reading on Smartkarma:- https://www.smartkarma.com/insights/china-healthcare-weekly-mar-31-8th-national-vbp-result-chinese-patent-medicine-vbp-aim-vaccine?utm_source=tiger_community
By Xinyao (Criss) Wang, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/xinyao-criss-wang?utm_source=tiger_community
On AIM Vaccine (06660):- https://www.smartkarma.com/entities/aim-vaccine-co-ltd?utm_source=tiger_community
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
